Annexin II and regulation of cell surface fibrinolysis

Annals of the New York Academy of Sciences

Volumn 902, Issue , 2000, Pages 265-271

  Hajjar, Katherine A ^a   Acharya, Suchitra S ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM BINDING PROTEIN; CELL SURFACE RECEPTOR; FIBRIN; LIPOCORTIN 2; PHOSPHOLIPID BINDING PROTEIN; PLASMINOGEN; TISSUE PLASMINOGEN ACTIVATOR;

ARTERY THROMBOSIS; ATHEROGENESIS; BINDING SITE; BLEEDING; BLOOD CELL; CELL SURFACE; CONFERENCE PAPER; ENDOTHELIUM CELL; FIBRINOLYSIS; GENE OVEREXPRESSION; HUMAN; NERVE CELL; PROMYELOCYTIC LEUKEMIA; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REGULATORY MECHANISM; SOLUBILIZATION; THROMBOGENESIS; TUMOR CELL;

EID: 0034050009     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb06321.x     Document Type: Conference Paper

References (30)

1. 1. HAJJAR, K.A. 1998. The molecular basis of fibrinolysis. In Hematology of Infancy and Childhood. D.G. Nathan & S.H. Orkin, Eds.: 1557-1573. W.B. Saunders Co. Philadelphia.
2. 2. LEVIN, E.G. & D.J. LOSKUTOFF. 1982. Cultured bovine endothelial cells produce both urokinase and tissue-type plasminogen activators. J. Cell Biol. 94: 631-636.
3. 3. LOSKUTOFF, D.J. & T.S. EDGINGTON. 1977. Synthesis of a fibrinolytic activator and inhibitor by endothelial cells. Proc. Natl. Acad. Sci. USA 74: 3903-3907.
4. 4. HAJJAR, K.A., P.C. HARPEL, E.A. JAFFE & R.L. NACHMAN. 1986. Binding of plasminogen to cultured human endothelial cells. J. Biol. Chem. 261: 11656-11662.
5. 5. HAJJAR, K.A., N.M. HAMEL, P.C. HARPEL & R.L. NACHMAN. 1987. Binding of tissue plasminogen activator to cultured human endothelial cells. J. Clin. Invest. 80: 1712-1719.
6. 6. HAJJAR, K.A. & N.M. HAMEL. 1990. Identification and characterization of human endothelial cell membrane binding sites for tissue plasminogen activator and urokinase. J. Biol. Chem. 265: 2908-2916.
7. 7. HAJJAR, K.A. 1991. The endothelial cell tissue plasminogen activator receptor: specific interaction with plasminogen. J. Biol. Chem. 266: 21962-21970.
8. 8. HAJJAR, K.A., A.T. JACOVINA & J. CHACKO. 1994. An endothelial cell receptor for plasminogen and tissue plasminogen activator: I. Identity with annexin II. J. Biol. Chem. 269: 21191-21197.
9. 9. HUANG, K., B.P. WALLINER, R.J. MATTALIANO, R. TIZARD, C. BURNEL, A. FREY, C. HESSION, P. MCGRAY, L.K. SINCLAIR, E.P. CHOW, J.L. BROWNING, K.L. RAMACHANDRAN et al. 1986. Two human 35 kd inhibitors of phospholipase A2 are related to substrates of pp60 v-src and of the epidermal growth factor receptor/kinase. Cell 46: 191-199.
10. 10. RAYNAL, P. & H.B. POLLARD. 1994. Annexins: the problem of assessing the biologic role for a gene family of multifunctional calcium-and phospholipid-binding proteins. Biochim. Biophys. Acta 1197: 63-93.
11. 11. SWAIRJO, M.A. & B.A. SEATON. 1994. Annexin structure and membrane interactions: A molecular perspective. Ann. Rev. Biophys. Biomol. Struct. 23: 193-213.
12. 12. TRESSLER, R.J., T.V. UPDYKE, T.J. YEATMAN & G.L. NICOLSON. 1993. Extracellular annexin is associated with divalent cation-dependent tumor cell adhesion of metastatic RAW 117 large-cell lymphoma cells. J. Cell. Biochem. 53: 265-276.
13. 13. CHUNG, C.Y. & H.P. ERICKSON. 1994. Cell surface annexin II is a high affinity receptor for the alternatively spliced segment of tenascin-C. J. Cell Biol. 126: 539-548.
14. 14. CHUNG, C.Y., J.E. MURPHY-ULLRICH & H.P. ERICKSON. 1996. Mitogenesis, cell migration and loss of focal adhesion induced by tenascin-C interacting with its cell surface receptor, annexin II. Mol. Biol. Cell. 7: 883-892.
15. 15. KRISTOFFERSEN, E.K. & R. MATRE. 1996. Surface annexin II on placental membranes of the fetomaternal interface. Am. J. Reprod. Immunol. 36: 141-149.
16. 16. WRIGHT, J.F., A. KUROSKY, E.L.G. PRYZDIAL & S. WASI. 1995. Host cellular annexin II is associated with cytomegalovirus particles isolated from cultured human fibro-blasts. J. Virol. 69: 4784-4791.
17. 17. BOLD, S., M. OHLIN, W. GARTEN & K. RADSAK. 1996. Structural domains involved in human cytomegalovirus glycoprotein B-mediated cell-cell fusion. J. Gen. Virol. 77: 2297-2302.
18. 18. HAJJAR, K.A., C.A. GUEVARA, E. LEV, K. DOWLING & J. CHACKO. 1996. Interaction of the fibrinolytic receptor, annexin II, with the endothelial cell surface: essential role of endonexin repeat 2. J. Biol. Chem. 271: 21652-21659.
19. 19. CESARMAN, G.M., C.A. GUEVARA & K.A. HAJJAR. 1994. An endothelial cell receptor for plasminogen/tissue plasminogen activator: II. Annexin II-mediated enhancement of t-PA-dependent plasminogen activation. J. Biol. Chem. 269: 21198-21203.
20. 20. KASSAM, G., K.S. CHOI, J. GHUMAN, H.M. KANG, S.L. FITZPATRICK, T. ZACKSON, S. ZACKSON, M. TOBA, A. SHINOMIYA & D.M. WAISMAN. 1998. The role of annexin II tetramer in the activation of plasminogen. J. Biol. Chem. 273: 4790-4799.
21. 21. KASSAM, G., B.H. LE, K.S. CHOI, H.M. KANG, L.P. FITZPATRICK & D.M. WAISMAN. 1998. The p11 subunit of the annexin II tetramer plays a key role in the stimulation of t-PA-dependent plasminogen activation. Biochemistry 37: 16958-16966.
22. 22. HAJJAR, K.A., L. MAURI, A.T. JACOVINA, F. ZHONG, U.A. MIRZA, J.C. PADOVAN & B.T. CHAIT. 1998. Tissue plasminogen activator binding to the annexin II tail domain: direct modulation by homocysteine. J. Biol. Chem. 273: 9987-9993.
23. 23. MCLEAN, J.W., J.E. TOMLINSON, W.J. KUANG, D.L. EATON, E.Y. CHEN, G.M. FLESS, A.M. SCANU & R.M. LAWN. 1987. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 330: 132-137.
24. 24. HAJJAR, K.A., D. GAVISH, J. BRESLOW & R.L. NACHMAN. 1989. Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis. Nature 339: 303-305.
25. 25. MUDD, H., H.L. LEVY & F. SKOVBY. 1995. Disorders of transsulfuration. In The Metabolic and Molecular Basis of Inherited Disease. C.R. Scriver, A.L. Beaudet, W.S. Sly & D. Valle, Eds.: 1279-1327. McGraw-Hill, Inc. New York.
26. 26. MUDD, H., F. SKOVBY, H.L. LEVY, K.D. PETTIGREW, B. WILCKEN, R.E., PYERITZ, G. ANDREA, G.H.J. BOERS, I.L. BROMBERG, R. CERONE, B. FOWLER, H. GROBE et al. 1985. The natural history of homocystinuria due to cystathionine β-synthase deficiency. Am. J. Hum. Gen. 37: 1-31.
27. 27. HAJJAR, K.A. 1993. Homocysteine-induced modulation of tissue plasminogen activator to its endothelial cell membrane receptor. J. Clin. Invest. 91: 2873-2879.
28. 28. DOMBRET, H., M.L. SCROBOHACI, P. GHORRA, J.M. ZINI, M.T. DANIEL, S. CASTAIGNE & L. DEGOS. 1993. Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all-trans retinoic acid treatment. Leukemia 7: 2-9.
29. 29. DOMBRET, H., M.L. SCROBOHACI, M.T. DANIEL, J.M. MICLEA, S. CASTAIGNE, C. CHOMIENNE, P. FENAUX & L. DEGOS. 1995. In vivo thrombin and plasmin activities in patients with acute promyelocytic leukemia (APL): Effect of all-trans-retinoic acid (ATRA) therapy. Leukemia 9: 19-24.
30. 30. MENELL, J.S., G.M. CESARMAN, A.T. JACOVINA, M.A. MCLAUGHLIN, E.A. LEV & K.A. HAJJAR. 1999. Annexin II and bleeding in acute promyelocytic leukemia. N. Engl. J. Med. 340: 994-1004.